Fibrocell Science Inc (FCSC.A)
FCSC.A on American Stock Exchange
5.16USD
10:45am EDT
5.16USD
10:45am EDT
Price Change (% chg)
$0.18 (+3.61%)
$0.18 (+3.61%)
Prev Close
$4.98
$4.98
Open
$5.05
$5.05
Day's High
$5.30
$5.30
Day's Low
$5.04
$5.04
Volume
7,947
7,947
Avg. Vol
--
--
52-wk High
$7.15
$7.15
52-wk Low
$4.55
$4.55
About
Fibrocell Science, Inc. is an aesthetic and therapeutic development stage biotechnology company focused on developing skin and tissue rejuvenation products. The Company’s clinical development product candidates are designed to improve the appearance of skin injured by the effects of aging, sun exposure, acne and burn scars with... (more)
No analyst recommendations are available for FCSC.A.
Overall
| Beta: | -0.22 |
| Market Cap (Mil.): | $130.64 |
| Shares Outstanding (Mil.): | 26.23 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| FCSC.A | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -1.24 | -- | -- |
| ROI: | -135.10 | -2.58 | 18.76 |
| ROE: | -249.02 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $93.82 | +0.32 |
| C.R. Bard, Inc. (BCR.N) | $115.67 | +1.07 |
| Integra Lifesciences Holdings Corp (IART.OQ) | $38.41 | -0.98 |
| Obagi Medical Products, Inc. (OMPI.OQ) | -- | -- |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$391.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

